PW Medtech Group Limited (HKG:1358)

Market Cap	1.91B +38.0%
Revenue (ttm)	925.78M +21.7%
Net Income	160.60M -3.8%
EPS	0.11 +0.0%
Shares Out	1.47B
PE Ratio	12.18
Forward PE	n/a
Dividend	0.10 (7.52%)
Ex-Dividend Date	Nov 3, 2025

Volume	66,000
Average Volume	490,900
Open	1.310
Previous Close	1.290
Day's Range	1.290 - 1.310
52-Week Range	0.940 - 1.630
Beta	0.57
RSI	45.00
Earnings Date	Mar 27, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical device...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 1,356
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1358

Financial Performance

In 2024, PW Medtech Group's revenue was 768.90 million, an increase of 13.90% compared to the previous year's 675.08 million. Earnings were 150.78 million, a decrease of -1.57%.

Financial numbers in CNY